Mikael Winkler, Ph.D.CTO & Co-founder at Commit BiologicsSpeaker
Profile
Mikael holds a PhD degree in Molecular Biology from Aarhus University in Denmark where he studied the structure and function of membrane proteins. He has extensive experience within structural biology, and his work on cholesterol and auxin transporters has been published in the high impact journals Nature and Cell. Following his PhD, Mikael worked together with the other founders on developing the BiCE™ technology.
Agenda Sessions
BiCE™ – An Antibody Platform to Potentiate Complement Activation for the Treatment of Cancer and Autoimmune Diseases
, 8:45amView Session